146 related articles for article (PubMed ID: 1933877)
1. Selective targeting of p53 gene mutational hotspots in human cancers by etiologically defined carcinogens.
Puisieux A; Lim S; Groopman J; Ozturk M
Cancer Res; 1991 Nov; 51(22):6185-9. PubMed ID: 1933877
[TBL] [Abstract][Full Text] [Related]
2. Methylated CpG dinucleotides are the preferential targets for G-to-T transversion mutations induced by benzo[a]pyrene diol epoxide in mammalian cells: similarities with the p53 mutation spectrum in smoking-associated lung cancers.
Yoon JH; Smith LE; Feng Z; Tang M; Lee CS; Pfeifer GP
Cancer Res; 2001 Oct; 61(19):7110-7. PubMed ID: 11585742
[TBL] [Abstract][Full Text] [Related]
3. The p53 codon 249 mutational hotspot in hepatocellular carcinoma is not related to selective formation or persistence of aflatoxin B1 adducts.
Denissenko MF; Koudriakova TB; Smith L; O'Connor TR; Riggs AD; Pfeifer GP
Oncogene; 1998 Dec; 17(23):3007-14. PubMed ID: 9881702
[TBL] [Abstract][Full Text] [Related]
4. Mutability of p53 hotspot codons to benzo(a)pyrene diol epoxide (BPDE) and the frequency of p53 mutations in nontumorous human lung.
Hussain SP; Amstad P; Raja K; Sawyer M; Hofseth L; Shields PG; Hewer A; Phillips DH; Ryberg D; Haugen A; Harris CC
Cancer Res; 2001 Sep; 61(17):6350-5. PubMed ID: 11522624
[TBL] [Abstract][Full Text] [Related]
5. Low frequency of p53 gene mutation in tumors induced by aflatoxin B1 in nonhuman primates.
Fujimoto Y; Hampton LL; Luo LD; Wirth PJ; Thorgeirsson SS
Cancer Res; 1992 Feb; 52(4):1044-6. PubMed ID: 1310637
[TBL] [Abstract][Full Text] [Related]
6. High frequency and heterogeneous distribution of p53 mutations in aflatoxin B1-induced mouse lung tumors.
Tam AS; Foley JF; Devereux TR; Maronpot RR; Massey TE
Cancer Res; 1999 Aug; 59(15):3634-40. PubMed ID: 10446974
[TBL] [Abstract][Full Text] [Related]
7. Mutational signature of the proximate bladder carcinogen N-hydroxy-4-acetylaminobiphenyl: inconsistency with the p53 mutational spectrum in bladder cancer.
Besaratinia A; Bates SE; Pfeifer GP
Cancer Res; 2002 Aug; 62(15):4331-8. PubMed ID: 12154037
[TBL] [Abstract][Full Text] [Related]
8. Carcinogens preferentially bind at methylated CpG in the p53 mutational hot spots.
Chen JX; Zheng Y; West M; Tang MS
Cancer Res; 1998 May; 58(10):2070-5. PubMed ID: 9605744
[TBL] [Abstract][Full Text] [Related]
9. Mutations in the tumor suppressor gene p53 in human liver cancer induced by alpha-particles.
Andersson M; Jönsson M; Nielsen LL; Vyberg M; Visfeldt J; Storm HH; Wallin H
Cancer Epidemiol Biomarkers Prev; 1995; 4(7):765-70. PubMed ID: 8672994
[TBL] [Abstract][Full Text] [Related]
10. [Environmental carcinogens and p53 gene mutation].
Xu Z; Jin Y
Wei Sheng Yan Jiu; 2004 Mar; 33(2):239-43. PubMed ID: 15209018
[TBL] [Abstract][Full Text] [Related]
11. Slow repair of bulky DNA adducts along the nontranscribed strand of the human p53 gene may explain the strand bias of transversion mutations in cancers.
Denissenko MF; Pao A; Pfeifer GP; Tang M
Oncogene; 1998 Mar; 16(10):1241-7. PubMed ID: 9546425
[TBL] [Abstract][Full Text] [Related]
12. p53 gene mutations in SKH-1 mouse tumors differentially induced by UVB and combined subcarcinogenic benzo[a]pyrene and UVA.
Wang Y; Zhou X; Weinstein E; Maryles B; Zhang Y; Moore J; Gao D; Atencio DP; Rosenstein BS; Lebwohl M; Chen HD; Xiao T; Wei H
Photochem Photobiol; 2008; 84(2):444-9. PubMed ID: 18248503
[TBL] [Abstract][Full Text] [Related]
13. p53 mutations in benzo(a)pyrene-exposed human p53 knock-in murine fibroblasts correlate with p53 mutations in human lung tumors.
Liu Z; Muehlbauer KR; Schmeiser HH; Hergenhahn M; Belharazem D; Hollstein MC
Cancer Res; 2005 Apr; 65(7):2583-7. PubMed ID: 15805253
[TBL] [Abstract][Full Text] [Related]
14. Comparison of mutations in the p53 and K-ras genes in lung carcinomas from smoking and nonsmoking women.
Gealy R; Zhang L; Siegfried JM; Luketich JD; Keohavong P
Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 1):297-302. PubMed ID: 10207632
[TBL] [Abstract][Full Text] [Related]
15. Complete and tissue-independent methylation of CpG sites in the p53 gene: implications for mutations in human cancers.
Tornaletti S; Pfeifer GP
Oncogene; 1995 Apr; 10(8):1493-9. PubMed ID: 7731703
[TBL] [Abstract][Full Text] [Related]
16. Mutagenic potential of benzo[a]pyrene-derived DNA adducts positioned in codon 273 of the human P53 gene.
Dong H; Bonala RR; Suzuki N; Johnson F; Grollman AP; Shibutani S
Biochemistry; 2004 Dec; 43(50):15922-8. PubMed ID: 15595848
[TBL] [Abstract][Full Text] [Related]
17. Sequence distribution of acetaldehyde-derived N2-ethyl-dG adducts along duplex DNA.
Matter B; Guza R; Zhao J; Li ZZ; Jones R; Tretyakova N
Chem Res Toxicol; 2007 Oct; 20(10):1379-87. PubMed ID: 17867647
[TBL] [Abstract][Full Text] [Related]
18. [Mapping DNA damage to understand somatic mutagenesis].
Lacoste S; Rochette PJ; Drouin R
Med Sci (Paris); 2010 Feb; 26(2):193-200. PubMed ID: 20188052
[TBL] [Abstract][Full Text] [Related]
19. Formation of diastereomeric benzo[a]pyrene diol epoxide-guanine adducts in p53 gene-derived DNA sequences.
Matter B; Wang G; Jones R; Tretyakova N
Chem Res Toxicol; 2004 Jun; 17(6):731-41. PubMed ID: 15206894
[TBL] [Abstract][Full Text] [Related]
20. p53 and K-ras mutations in lung cancers from former and never-smoking women.
Vähäkangas KH; Bennett WP; Castrén K; Welsh JA; Khan MA; Blömeke B; Alavanja MC; Harris CC
Cancer Res; 2001 Jun; 61(11):4350-6. PubMed ID: 11389059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]